Abstract
Abstract In vitro studies suggest that vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) may stimulate release of nitric oxide (NO) from endothelial cells. To investigate the hemodynamic consequences of recombinant VEGF/VPF administered in vivo, recombinant human VEGF/VPF was administered as a bolus dose of 500 μg to anesthetized (n=6) or conscious (n=5) New Zealand White rabbits, as well as anesthetized rabbits with diet-induced hypercholesterolemia (HC; n=7). Anesthetized Yorkshire farm pigs (no specific dietary pretreatment) were studied before and after receiving 500 μg intravenous (IV; n=5) or intracoronary (IC; n=5) VEGF/VPF. In anesthetized, normal rabbits, mean arterial pressure (MAP) fell by 20.5±1.4% ( P
Cite
CITATION STYLE
Horowitz, J. R., Rivard, A., van der Zee, R., Hariawala, M., Sheriff, D. D., Esakof, D. D., … Isner, J. M. (1997). Vascular Endothelial Growth Factor/Vascular Permeability Factor Produces Nitric Oxide–Dependent Hypotension. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(11), 2793–2800. https://doi.org/10.1161/01.atv.17.11.2793
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.